Recent Articles

December 4, 2017 1:53 pm
Christopher Dowdy, Client and Scientific Portfolio Manager, Charles River
Less than four years since the groundbreaking study linking gut microbiota to obesity, the race to develop microbiome therapies is in full sprint.
November 13, 2017 10:59 am
Rupert Yip, Director of Global Product Management for Genetic Disease, QIAGEN Bioinformatics
Delving deeper into genome sequences has highlighted the stark difference between information and insight.
November 13, 2017 11:02 am
Gunjot Rana
One of the most important tools for dealing with this the antibiotic resistant challenge is rapid molecular testing.
October 31, 2017 4:00 pm
Joanne Van Zuidam
Blood-sucking vampire or blood disorder? A new study from Boston’s Children’s Hospital has discovered a genetic mutations that triggers a disease linked to vampire folklore.
October 19, 2017 12:57 pm
Joanne Van Zuidam
Kite Pharma’s Yescarta, a chimeric antigen receptor (CAR) T cell therapy, is the second gene therapy approved by the FDA and the first for certain types of non-Hodgkin lymphoma (NHL).
Subscribe to Bioscience Technology